Home
Seagen Inc and Genmab Announce FDA Accelerated Approval for TIVDAK™ for Cervical Cancer

Seagen Inc and Genmab Announce FDA Accelerated Approval for TIVDAK™ for Cervical Cancer

Today’s Highlights September 21, 2021

Seagen and Genmab Granted FDA Accelerated Approval for TIVDAK™
The U.S. FDA granted accelerated approval to Seagen Inc (SGEN) and Genmab A/S (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
,
September 21, 2021

Other Articles